Latest in Underwhelms

Sort by

3 items

Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms

Amgen’s MariTide achieved up to 20% weight loss in a mid-stage trial, but analysts were expecting up to 25%.
Business - MarketWatch - 1 hour ago
AstraZeneca sheds £15 billion of market cap as weight-loss-pill data underwhelms investors

AstraZeneca PLC shed £15 billion in market capitalization on Tuesday, after investors were underwhelmed by early data from a trial of a weight-loss pill.
Business - MarketWatch - November 5

Amgen’s stock closes off lows to avoid worst day in 24 years as weight-loss-drug data underwhelms